Palo Alto Investors »

Newamsterdam Pharma Co Nv shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 44k 33.89

More positions owned by Palo Alto Investors

Ptc Therapeutics I (PTCT)
ACADIA Pharmaceuticals (ACAD)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Anaptysbio Inc Common (ANAB)
BioMarin Pharmaceutical (BMRN)
Dyne Therapeutics (DYN)
United Therapeutics Corporation (UTHR)
Disc Medicine (IRON)
Biogen Idec (BIIB)
Iovance Biotherapeutics (IOVA)
Ultragenyx Pharmaceutical (RARE)
Novocure Ord Shs (NVCR)
Syndax Pharmaceuticals (SNDX)
Annexon (ANNX)

View all positions for Palo Alto Investors

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Capital World Investors
FMR
RA Capital Management
Fcpm Iii Services B.v.
Deerfield Management Company
Viking Global Investors
Bain Capital Life Sciences Investors
Maverick Capital
Duquesne Family Office
Jupiter Topco
Henderson Group
Medicxi Ventures Management
Jennison Associates
Orbis Allan Gray

View all funds holding Newamsterdam Pharma Co Nv